coronavirus image

As the Quality Innovation Network – Quality Improvement Organization for North Dakota and South Dakota, Great Plains Quality Innovation Network has been asked to communicate COVID-19 data collection and reporting requirements to all hospitals in our two states. The data collected will help decision makers better understand disease patterns and develop policies for prevention and control of health problems related to COVID-19.

Per the linked memo from Vice President Mike Pence, all hospitals are to report data on COVID-19 testing performed in all academic/university/hospital ‘in house’ laboratories. If your testing is sent to commercial labs, you are exempt from this request. This data is due each day by 5:00 p.m. ET. The attached memo provides specifics on reporting requirements, submission guidelines and exemptions. For all questions related to this guidance, contact fema-hhs-covid-diagnostics-tf@fema.dhs.gov

As part of CDC’s ongoing COVID-19 response, a new Patient Impact Module has been created in NHSN to help facilities track and monitor the number of cases reported in their facilities daily. To monitor the rapid emergence of COVID-19 and its impact, all hospitals are to report to the NHSN  COVID-19 Patient Impact and Hospital Capacity Module. All hospitals that currently utilize the NHSN should have received an email from the Centers for Disease Control and Prevention (CDC) outlining this request. For questions on this module or submission requirements, contact NHSN@cdc.gov and put “COVID-19 Module” in the subject line.

We have linked to the following documents to assist in better understanding this request.

Thank you to all hospital staff for your critical work to help those patients impacted by COVID-19;  your communities appreciate you more than you know.